CN110591990A - 一株高产核黄素工程菌株及其应用 - Google Patents
一株高产核黄素工程菌株及其应用 Download PDFInfo
- Publication number
- CN110591990A CN110591990A CN201910604170.3A CN201910604170A CN110591990A CN 110591990 A CN110591990 A CN 110591990A CN 201910604170 A CN201910604170 A CN 201910604170A CN 110591990 A CN110591990 A CN 110591990A
- Authority
- CN
- China
- Prior art keywords
- riboflavin
- strain
- mutagenesis
- yield
- bacillus subtilis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 199
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 100
- 229960002477 riboflavin Drugs 0.000 claims abstract description 100
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 99
- 239000002151 riboflavin Substances 0.000 claims abstract description 99
- 238000004519 manufacturing process Methods 0.000 claims abstract description 25
- 210000004027 cell Anatomy 0.000 claims abstract description 24
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 15
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 15
- 230000035772 mutation Effects 0.000 claims abstract description 14
- 210000000349 chromosome Anatomy 0.000 claims abstract description 13
- 238000010276 construction Methods 0.000 claims abstract description 11
- 101150060382 ribC gene Proteins 0.000 claims abstract description 11
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 4
- 101150079601 recA gene Proteins 0.000 claims abstract description 4
- 230000015556 catabolic process Effects 0.000 claims abstract description 3
- 238000004321 preservation Methods 0.000 claims abstract description 3
- 238000000855 fermentation Methods 0.000 claims description 34
- 230000004151 fermentation Effects 0.000 claims description 34
- 238000002703 mutagenesis Methods 0.000 claims description 29
- 231100000350 mutagenesis Toxicity 0.000 claims description 29
- 238000012216 screening Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000013612 plasmid Substances 0.000 claims description 11
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 claims description 9
- 238000013537 high throughput screening Methods 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 239000013613 expression plasmid Substances 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000007790 scraping Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 238000010353 genetic engineering Methods 0.000 abstract description 5
- 238000002744 homologous recombination Methods 0.000 abstract description 2
- 230000033616 DNA repair Effects 0.000 abstract 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 231100000225 lethality Toxicity 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000009395 breeding Methods 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 241000282326 Felis catus Species 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 230000004927 fusion Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 101100356737 Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) ribCF gene Proteins 0.000 description 4
- 101100010154 Streptomyces ribosidificus rbmA gene Proteins 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000012269 metabolic engineering Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 101150073450 ribE gene Proteins 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- SGSVWAYHEWEQET-SCRDCRAPSA-N 1,5-dihydroriboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O SGSVWAYHEWEQET-SCRDCRAPSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006652 catabolic pathway Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- 229940013640 flavin mononucleotide Drugs 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000006825 purine synthesis Effects 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 101100112372 Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) catM gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 101150053553 catR gene Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P25/00—Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910604170.3A CN110591990B (zh) | 2019-07-05 | 2019-07-05 | 一株高产核黄素工程菌株及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910604170.3A CN110591990B (zh) | 2019-07-05 | 2019-07-05 | 一株高产核黄素工程菌株及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110591990A true CN110591990A (zh) | 2019-12-20 |
CN110591990B CN110591990B (zh) | 2021-09-07 |
Family
ID=68852743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910604170.3A Active CN110591990B (zh) | 2019-07-05 | 2019-07-05 | 一株高产核黄素工程菌株及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110591990B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111393514A (zh) * | 2020-06-03 | 2020-07-10 | 中国科学院天津工业生物技术研究所 | 过氧化物转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 |
CN112225785A (zh) * | 2020-10-23 | 2021-01-15 | 中国科学院天津工业生物技术研究所 | GntR家族转录抑制因子突变体、突变基因及其在制备维生素B2中的应用 |
CN112575021A (zh) * | 2020-12-15 | 2021-03-30 | 通辽梅花生物科技有限公司 | 一种生产核黄素的方法 |
CN113073074A (zh) * | 2021-04-12 | 2021-07-06 | 江南大学 | 一种高效合成核黄素的基因工程菌及其应用 |
CN114181963A (zh) * | 2021-12-07 | 2022-03-15 | 上海市农业科学院 | 一种利用dna改组提高大肠杆菌工程菌产核黄素能力的方法 |
WO2022127039A1 (zh) * | 2020-12-15 | 2022-06-23 | 通辽梅花生物科技有限公司 | 一种产核黄素的枯草芽孢杆菌及其构建方法与应用 |
CN114854780A (zh) * | 2022-04-13 | 2022-08-05 | 江南大学 | 一种基于平衡基因表达高效合成核黄素的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1891813A (zh) * | 2006-05-17 | 2007-01-10 | 天津大学 | 产核黄素的工程菌株及其构建方法 |
CN105483071A (zh) * | 2015-12-29 | 2016-04-13 | 天津大学 | 一种高产核黄素大肠杆菌工程菌株及构建及发酵方法 |
CN108277189A (zh) * | 2017-01-05 | 2018-07-13 | 上海创诺医药集团有限公司 | 一种生产核黄素的工程菌株及其应用 |
CN109198214A (zh) * | 2018-10-30 | 2019-01-15 | 上海市农业科学院 | 一种发酵饲料、制备方法及其配合饲料 |
CN111393515A (zh) * | 2020-06-03 | 2020-07-10 | 中国科学院天津工业生物技术研究所 | 核糖核苷酸还原酶转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 |
CN112225785A (zh) * | 2020-10-23 | 2021-01-15 | 中国科学院天津工业生物技术研究所 | GntR家族转录抑制因子突变体、突变基因及其在制备维生素B2中的应用 |
CN112538453A (zh) * | 2020-12-15 | 2021-03-23 | 通辽梅花生物科技有限公司 | 一种产核黄素的枯草芽孢杆菌及其构建方法与应用 |
CN113025550A (zh) * | 2021-05-24 | 2021-06-25 | 中国科学院天津工业生物技术研究所 | 高产维生素b2枯草芽孢杆菌工程菌株、其构建及应用 |
-
2019
- 2019-07-05 CN CN201910604170.3A patent/CN110591990B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1891813A (zh) * | 2006-05-17 | 2007-01-10 | 天津大学 | 产核黄素的工程菌株及其构建方法 |
CN105483071A (zh) * | 2015-12-29 | 2016-04-13 | 天津大学 | 一种高产核黄素大肠杆菌工程菌株及构建及发酵方法 |
CN108277189A (zh) * | 2017-01-05 | 2018-07-13 | 上海创诺医药集团有限公司 | 一种生产核黄素的工程菌株及其应用 |
CN109198214A (zh) * | 2018-10-30 | 2019-01-15 | 上海市农业科学院 | 一种发酵饲料、制备方法及其配合饲料 |
CN111393515A (zh) * | 2020-06-03 | 2020-07-10 | 中国科学院天津工业生物技术研究所 | 核糖核苷酸还原酶转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 |
CN112225785A (zh) * | 2020-10-23 | 2021-01-15 | 中国科学院天津工业生物技术研究所 | GntR家族转录抑制因子突变体、突变基因及其在制备维生素B2中的应用 |
CN112538453A (zh) * | 2020-12-15 | 2021-03-23 | 通辽梅花生物科技有限公司 | 一种产核黄素的枯草芽孢杆菌及其构建方法与应用 |
CN113025550A (zh) * | 2021-05-24 | 2021-06-25 | 中国科学院天津工业生物技术研究所 | 高产维生素b2枯草芽孢杆菌工程菌株、其构建及应用 |
Non-Patent Citations (2)
Title |
---|
WANG, GL,ET AL: "Integrated whole-genome and transcriptome sequence analysis reveals the genetic characteristics of a riboflavin-overproducing Bacillus subtilis", 《METABOLIC ENGINEERING》 * |
张大伟等: "枯草芽孢杆菌在系统与合成生物技术中研究进展及工业应用", 《生物工程学报》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111393514A (zh) * | 2020-06-03 | 2020-07-10 | 中国科学院天津工业生物技术研究所 | 过氧化物转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 |
CN111393514B (zh) * | 2020-06-03 | 2020-08-21 | 中国科学院天津工业生物技术研究所 | 过氧化物转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 |
CN112225785A (zh) * | 2020-10-23 | 2021-01-15 | 中国科学院天津工业生物技术研究所 | GntR家族转录抑制因子突变体、突变基因及其在制备维生素B2中的应用 |
CN112575021A (zh) * | 2020-12-15 | 2021-03-30 | 通辽梅花生物科技有限公司 | 一种生产核黄素的方法 |
WO2022127039A1 (zh) * | 2020-12-15 | 2022-06-23 | 通辽梅花生物科技有限公司 | 一种产核黄素的枯草芽孢杆菌及其构建方法与应用 |
CN113073074A (zh) * | 2021-04-12 | 2021-07-06 | 江南大学 | 一种高效合成核黄素的基因工程菌及其应用 |
CN113073074B (zh) * | 2021-04-12 | 2022-09-06 | 江南大学 | 一种高效合成核黄素的基因工程菌及其应用 |
CN114181963A (zh) * | 2021-12-07 | 2022-03-15 | 上海市农业科学院 | 一种利用dna改组提高大肠杆菌工程菌产核黄素能力的方法 |
CN114854780A (zh) * | 2022-04-13 | 2022-08-05 | 江南大学 | 一种基于平衡基因表达高效合成核黄素的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110591990B (zh) | 2021-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110591990B (zh) | 一株高产核黄素工程菌株及其应用 | |
CN106190921B (zh) | 一种谷氨酸棒状杆菌与应用 | |
MXPA06014165A (es) | Cepas de saccharomyces no recombinantes que se desarrolan sobre xilosa. | |
CN111393515B (zh) | 核糖核苷酸还原酶转录抑制因子突变体、突变基因及其在制备维生素b2中的应用 | |
CN1891813A (zh) | 产核黄素的工程菌株及其构建方法 | |
CN109971676B (zh) | 一种高产异亮氨酸的谷氨酸棒状杆菌的选育方法及应用 | |
CN110591989A (zh) | 一株高产l-色氨酸工程菌株及其应用 | |
CN104195190B (zh) | 一种利用重组大肠杆菌厌氧生产5‑氨基乙酰丙酸的方法 | |
US20110020937A1 (en) | Flocculent yeast and method for production thereof | |
Bai et al. | Strain improvement and metabolic flux analysis in the wild‐type and a mutant Lactobacillus lactis strain for l (+)‐lactic acid production | |
Oliveira et al. | Pseudozyma brasiliensis sp. nov., a xylanolytic, ustilaginomycetous yeast species isolated from an insect pest of sugarcane roots | |
CN103361289A (zh) | 一株产l-赖氨酸的菌株及其生产l-赖氨酸的方法 | |
CN105287622A (zh) | No累积降低铜绿假单胞菌侵袭力的方法、靶点及应用 | |
Edwards et al. | Changes in oxygen uptake rates, enzyme activities, cytochrome amounts and adenine nucleotide pool levels during growth of Acanthamoeba castellanii in batch culture | |
CN105925519A (zh) | 一种在辅酶q10生产菌株sz中降低或消除副产物d的方法、辅酶q10高产菌株及其应用 | |
Poshekhontseva et al. | Streptomyces tsukubensis VKM Aс-2618D—an Effective Producer of Tacrolimus | |
Tritz et al. | Recognition of a gene involved in the regulation of nicotinamide adenine dinucleotide biosynthesis | |
CN106635945A (zh) | 重组菌株及其制备方法和生产l‑苏氨酸的方法 | |
CN113717886B (zh) | 一种凝结芽孢杆菌及其催化生产2’-脱氧腺苷的方法 | |
CN107674839B (zh) | 一种腐皮镰刀菌及其发酵生产右旋糖酐酶的方法 | |
CN113604390B (zh) | 一株谷氨酸棒杆菌及其在发酵生产l-鸟氨酸中的应用 | |
CN109929853B (zh) | 嗜热菌来源的热激蛋白基因的应用 | |
CN110106098B (zh) | 一种高产丙酮酸的酿酒酵母工程菌株及其发酵方法 | |
CN114134056A (zh) | 酿酒酵母zjs10041及其在发酵产s-腺苷蛋氨酸中的应用 | |
CN106010999A (zh) | 基因工程菌株、培养方法及该基因工程菌株的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240429 Address after: No. 15 West 8th Road, Airport Economic Zone, Binhai New Area, Tianjin, 300308 Patentee after: Tianjin National Synthetic Biotechnology Innovation Center Co.,Ltd. Country or region after: China Address before: No.32, Xiqi Road, Tianjin Airport Economic Zone, Binhai New Area, Tianjin 300308 Patentee before: TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES Country or region before: China |
|
TR01 | Transfer of patent right |